Literature DB >> 21903112

Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method.

Susan J Bartko1, Carola Romberg, Benjamin White, Jürgen Wess, Timothy J Bussey, Lisa M Saksida.   

Abstract

Cholinergic receptors have been implicated in schizophrenia, Alzheimer's disease, Parkinson's disease, and Huntington's disease. However, to better target therapeutically the appropriate receptor subsystems, we need to understand more about the functions of those subsystems. In the current series of experiments, we assessed the functional role of M(1) receptors in cognition by testing M(1) receptor-deficient mice (M1R(-/-)) on the five-choice serial reaction time test of attentional and response functions, carried out using a computer-automated touchscreen test system. In addition, we tested these mice on several tasks featuring learning, memory and perceptual challenges. An advantage of the touchscreen method is that each test in the battery is carried out in the same task setting, using the same types of stimuli, responses and feedback, thus providing a high level of control and task comparability. The surprising finding, given the predominance of the M(1) receptor in cortex, was the complete lack of effect of M(1) deletion on measures of attentional function per se. Moreover, M1R(-/-) mice performed relatively normally on tests of learning, memory and perception, although they were impaired in object recognition memory with, but not without an interposed delay interval. They did, however, show clear abnormalities on a variety of response measures: M1R(-/-) mice displayed fewer omissions, more premature responses, and increased perseverative responding compared to wild-types. These data suggest that M1R(-/-) mice display abnormal responding in the face of relatively preserved attention, learning and perception.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903112      PMCID: PMC3899542          DOI: 10.1016/j.neuropharm.2011.08.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  69 in total

Review 1.  Muscarinic receptor ligands and their therapeutic potential.

Authors:  R M Eglen; A Choppin; M P Dillon; S Hegde
Journal:  Curr Opin Chem Biol       Date:  1999-08       Impact factor: 8.822

2.  Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice.

Authors:  Stephan G Anagnostaras; Geoffrey G Murphy; Susan E Hamilton; Scott L Mitchell; Nancy P Rahnama; Neil M Nathanson; Alcino J Silva
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

3.  Selective behavioral and neurochemical effects of cholinergic lesions produced by intrabasalis infusions of 192 IgG-saporin on attentional performance in a five-choice serial reaction time task.

Authors:  J McGaughy; J W Dalley; C H Morrison; B J Everitt; T W Robbins
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 4.  The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.

Authors:  T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2002-08-09       Impact factor: 4.530

5.  The role of nicotinic and muscarinic acetylcholine receptors in attention.

Authors:  N R Mirza; I P Stolerman
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

Review 6.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

Review 7.  Muscarinic receptors in schizophrenia.

Authors:  B Dean; F P Bymaster; E Scarr
Journal:  Curr Mol Med       Date:  2003-08       Impact factor: 2.222

8.  Stimulus-bound perseveration after frontal ablations in marmosets.

Authors:  R M Ridley; B A Clark; L J Durnford; H F Baker
Journal:  Neuroscience       Date:  1993-02       Impact factor: 3.590

9.  The touchscreen cognitive testing method for rodents: how to get the best out of your rat.

Authors:  Timothy J Bussey; Tina L Padain; Elizabeth A Skillings; Boyer D Winters; A Jennifer Morton; Lisa M Saksida
Journal:  Learn Mem       Date:  2008-07-08       Impact factor: 2.460

10.  Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit.

Authors:  Jonathan L Brigman; Michael Feyder; Lisa M Saksida; Timothy J Bussey; Masayoshi Mishina; Andrew Holmes
Journal:  Learn Mem       Date:  2008-01-28       Impact factor: 2.460

View more
  30 in total

1.  Forebrain deletion of the vesicular acetylcholine transporter results in deficits in executive function, metabolic, and RNA splicing abnormalities in the prefrontal cortex.

Authors:  Benjamin Kolisnyk; Mohammed A Al-Onaizi; Pedro H F Hirata; Monica S Guzman; Simona Nikolova; Shahar Barbash; Hermona Soreq; Robert Bartha; Marco A M Prado; Vania F Prado
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  The NEWMEDS rodent touchscreen test battery for cognition relevant to schizophrenia.

Authors:  M Hvoslef-Eide; A C Mar; S R O Nilsson; J Alsiö; C J Heath; L M Saksida; T W Robbins; T J Bussey
Journal:  Psychopharmacology (Berl)       Date:  2015-07-24       Impact factor: 4.530

3.  Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice.

Authors:  R W Gould; D Dencker; M Grannan; M Bubser; X Zhan; J Wess; Z Xiang; C Locuson; C W Lindsley; P J Conn; C K Jones
Journal:  ACS Chem Neurosci       Date:  2015-08-05       Impact factor: 4.418

Review 4.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

5.  Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task.

Authors:  C M Fitzpatrick; M Caballero-Puntiverio; U Gether; T Habekost; C Bundesen; S Vangkilde; D P D Woldbye; J T Andreasen; A Petersen
Journal:  Psychopharmacology (Berl)       Date:  2017-01-09       Impact factor: 4.530

Review 6.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

7.  The pharmacological sensitivity of a touchscreen-based visual discrimination task in the rat using simple and perceptually challenging stimuli.

Authors:  J C Talpos; A C Fletcher; C Circelli; M D Tricklebank; S L Dix
Journal:  Psychopharmacology (Berl)       Date:  2011-11-26       Impact factor: 4.530

8.  Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.

Authors:  Joshua D Vardigan; Christopher E Cannon; Vanita Puri; Mandy Dancho; AmyJo Koser; Marion Wittmann; Scott D Kuduk; John J Renger; Jason M Uslaner
Journal:  Psychopharmacology (Berl)       Date:  2014-12-10       Impact factor: 4.530

Review 9.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

10.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.

Authors:  Michael D Grannan; Catharine A Mielnik; Sean P Moran; Robert W Gould; Jacob Ball; Zhuoyan Lu; Michael Bubser; Amy J Ramsey; Masahito Abe; Hyekyung P Cho; Kellie D Nance; Anna L Blobaum; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2016-10-05       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.